These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 18601303)

  • 1. Role of cannabinoids in the management of neuropathic pain.
    Martín Fontelles MI; Goicoechea García C
    CNS Drugs; 2008; 22(8):645-53. PubMed ID: 18601303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.
    Rahn EJ; Hohmann AG
    Neurotherapeutics; 2009 Oct; 6(4):713-37. PubMed ID: 19789075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.
    Boychuk DG; Goddard G; Mauro G; Orellana MF
    J Oral Facial Pain Headache; 2015; 29(1):7-14. PubMed ID: 25635955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.
    Iskedjian M; Bereza B; Gordon A; Piwko C; Einarson TR
    Curr Med Res Opin; 2007 Jan; 23(1):17-24. PubMed ID: 17257464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current evidence of cannabinoid-based analgesia obtained in preclinical and human experimental settings.
    Lötsch J; Weyer-Menkhoff I; Tegeder I
    Eur J Pain; 2018 Mar; 22(3):471-484. PubMed ID: 29160600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cannabinoids for neuropathic pain management].
    Andersen LØ; Enggaard TP; Højsted J
    Ugeskr Laeger; 2018 Feb; 180(9):. PubMed ID: 29506645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the role of cannabinoids as modulators of Wnt/β-catenin signaling pathway for their use in the management of neuropathic pain.
    Nalli Y; Dar MS; Bano N; Rasool JU; Sarkar AR; Banday J; Bhat AQ; Rafia B; Vishwakarma RA; Dar MJ; Ali A
    Bioorg Med Chem Lett; 2019 May; 29(9):1043-1046. PubMed ID: 30871771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The endocannabinoid system and neuropathic pain.
    Maldonado R; Baños JE; Cabañero D
    Pain; 2016 Feb; 157 Suppl 1():S23-S32. PubMed ID: 26785153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
    Petzke F; Enax-Krumova EK; Häuser W
    Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathic orofacial pain: cannabinoids as a therapeutic avenue.
    McDonough P; McKenna JP; McCreary C; Downer EJ
    Int J Biochem Cell Biol; 2014 Oct; 55():72-8. PubMed ID: 25150831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoids for neuropathic pain.
    Fine PG; Rosenfeld MJ
    Curr Pain Headache Rep; 2014 Oct; 18(10):451. PubMed ID: 25160710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain.
    Soliman N; Haroutounian S; Hohmann AG; Krane E; Liao J; Macleod M; Segelcke D; Sena C; Thomas J; Vollert J; Wever K; Alaverdyan H; Barakat A; Barthlow T; Bozer ALH; Davidson A; Diaz-delCastillo M; Dolgorukova A; Ferdousi MI; Healy C; Hong S; Hopkins M; James A; Leake HB; Malewicz NM; Mansfield M; Mardon AK; Mattimoe D; McLoone DP; Noes-Holt G; Pogatzki-Zahn EM; Power E; Pradier B; Romanos-Sirakis E; Segelcke A; Vinagre R; Yanes JA; Zhang J; Zhang XY; Finn DP; Rice ASC
    Pain; 2021 Jul; 162(Suppl 1):S26-S44. PubMed ID: 33729209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials.
    Lynch ME; Campbell F
    Br J Clin Pharmacol; 2011 Nov; 72(5):735-44. PubMed ID: 21426373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cannabinoids for the treatment of chronic pain - an overview of current medical knowledge].
    Gras-Ozimek J; Kozińska U; Gras-Ozimek A
    Pol Merkur Lekarski; 2022 Aug; 50(298):257-261. PubMed ID: 36086988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis.
    Meng H; Johnston B; Englesakis M; Moulin DE; Bhatia A
    Anesth Analg; 2017 Nov; 125(5):1638-1652. PubMed ID: 28537982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of cannabinoids in palliative medicine].
    Ernst G; Kongsgaard UE
    Tidsskr Nor Laegeforen; 2008 Apr; 128(7):822-5. PubMed ID: 18389029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis for Chronic Pain: A Rapid Systematic Review of Randomized Control Trials.
    Longo R; Oudshoorn A; Befus D
    Pain Manag Nurs; 2021 Apr; 22(2):141-149. PubMed ID: 33353819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids for the treatment of neuropathic pain: clinical evidence.
    Ashton JC; Milligan ED
    Curr Opin Investig Drugs; 2008 Jan; 9(1):65-75. PubMed ID: 18183533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systematic review of safeness and therapeutic efficacy of cannabis in patients with multiple sclerosis, neuropathic pain, and in oncological patients treated with chemotherapy].
    Amato L; Minozzi S; Mitrova Z; Parmelli E; Saulle R; Cruciani F; Vecchi S; Davoli M
    Epidemiol Prev; 2017; 41(5-6):279-293. PubMed ID: 29119763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The pharmacology of cannabinoid derivatives: are there applications to treatment of pain?].
    Beaulieu P; Rice AS
    Ann Fr Anesth Reanim; 2002 Jun; 21(6):493-508. PubMed ID: 12134594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.